|
End-of-day quote
Ghana S.E.
|
||
| - GHS | - |
|
| Market Cap | 5.2M 60.76M 4.66M 4.29M 3.9M 7.38M 487M 7.59M 51.42M 20.49M 261M 19.5M 19.09M 825M | P/E 2017 |
11.7x | P/E 2018 | 6.9x |
|---|---|---|---|---|---|
| Enterprise Value | 10.45M 122M 9.37M 8.63M 7.84M 14.84M 979M 15.25M 103M 41.19M 525M 39.2M 38.37M 1.66B | EV / Sales 2017 |
1.34x | EV / Sales 2018 | 1.05x |
| Free-Float |
26.89% | Yield 2017 * |
-
| Yield 2018 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 915K | |
| +1.44% | +1.63% | +48.17% | +139.63% | 1,276B | |
| -0.47% | +5.49% | +49.03% | +90.68% | 676B | |
| +0.20% | +2.76% | +34.37% | +112.06% | 519B | |
| -0.78% | +0.88% | +38.34% | +67.29% | 388B | |
| -0.48% | +2.34% | +70.66% | +46.02% | 365B | |
| -1.12% | -0.82% | +27.94% | +57.36% | 307B | |
| -0.24% | -1.11% | +2.99% | +35.32% | 287B | |
| 0.00% | +0.86% | +43.74% | +74.04% | 252B | |
| +0.92% | +2.03% | +44.62% | +125.07% | 212B | |
| Average | -0.52% | +2.34% | +39.99% | +83.05% | 428B | |
| Weighted average by Cap. | -0.77% | +2.51% | +42.74% | +96.55% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 8.89M 104M 7.97M 7.35M 6.67M 12.63M 834M 12.99M 88M 35.06M 447M 33.37M 32.67M 1.41B | 9.91M 116M 8.89M 8.19M 7.44M 14.08M 929M 14.47M 98.06M 39.07M 498M 37.19M 36.4M 1.57B |
| Net income | 665K 7.78M 596K 550K 499K 945K 62.35M 971K 6.58M 2.62M 33.41M 2.5M 2.44M 106M | 762K 8.9M 683K 629K 572K 1.08M 71.4M 1.11M 7.54M 3M 38.25M 2.86M 2.8M 121M |
| Net Debt | 4.15M 48.49M 3.72M 3.43M 3.11M 5.89M 389M 6.06M 41.04M 16.35M 208M 15.56M 15.23M 659M | 5.25M 61.38M 4.71M 4.34M 3.94M 7.46M 492M 7.67M 51.95M 20.7M 264M 19.7M 19.28M 834M |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- SPL Stock
Select your edition
All financial news and data tailored to specific country editions
